Assessment of atherothrombosis and its treatment in Mexico: First-year data of the REACH registry

Clinical Cardiology

Volumn 33, Issue 7, 2010, Pages 445-451

  Gaxiola, Efraín ^a   Eng Ceceña, Luis ^b   Ortiz Galván, Fernando ^b   Llamas López, Leonardo ^c   Rangel Guerra, Ricardo ^d   Alcocer Gamba, Marco Antonio ^e   Bhatt, Deepak L ^f   Steg, P Gabriel ^g   Velasco, Arturo Abundes ^b   Aguayo, Geronimo ^b   Alexanderson, Graciela ^b   Alpizar, Melchor ^b   Amaya, Luis Enrique ^b   Arauz, Antonio ^b   Astorga, Armando ^b   Azpiri, Jose Ramon ^b   Barinagarrementeria, Fernando ^b   Estrada, Enrique Bernal ^b   Briseno Ramirez, Hector Manuel ^b   Calvo, Cesar ^b   Cantu Brito, Carlos ^b   Colorado, Hector ^b   Cortes, Jorge ^b   Cossio, Jorge ^b   De Los Rios Ibarra, Manuel Odin ^b   De Zatarain, Rodrigo ^b   Diaz, Carlos ^b   Eng, Luis ^b   Esparragoza, Jesus ^b   Sierra, Luis Espinosa ^b   Espinoza, Carlos ^b   Bonetti, Pedro Fernandez ^b   Cantu, Elias Garcia ^b   Martinez, Rodrigo Garcia ^b   Guerra, Alejandro Garza ^b   Gonzalez Camid, Felipe De Jesus ^b   Pasqueira, Francisco Guerrero ^b   Hernandez, Ismael ^b   Kostine, Andrei ^b   Leiva, Jose Luis ^b   Lopez, Berenice ^b   Cuellar, Julio Lopez ^b   Meneses, Mauricio Lopez ^b   Marcos, Antonio ^b   Lopez, Sergio Najar ^b   Nettel, Jacobo ^b   Peralta, Rogelio ^b   Perez Garcia, Juan Carlos ^b   Ranero, Alejandra ^b   Rodriguez, Joel ^b   Leyva, Ildefonso Rodriguez ^b   Rojas, Jose Alberto ^b   Romero, Aldo ^b   Rubio, Gustavo ^b   Ruiz, Jose Luis ^b   Sagastegui, Alberto ^b   Talamas, Oscar ^b   Tapia, Monica ^b   Toriz Melchor, Jose Luis Antonio ^b   Uribe, Artemio ^b   Vazquez, Jorge ^b   Velasco, Jose Antonio ^b   Velasco Ortega, Erich Carlos ^b   Velasco Sanchez, Raul Gerardo ^b   Villarreal, Jorge ^b   more..

^a Department of Cardiology   (Mexico)

^b Department of Neurology Hospital Regional Dr Valentín Gómez Farías ISSSTE ^*

^c Hospital Regional Dr Valentin Gomez Farias   (Mexico)

^d Hospital Muguerza Alta Especialidad   (Mexico)

^e Instituto de Corazon de   (Mexico)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLSALICYLIC ACID; ANGIOTENSIN II ANTAGONIST; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; SULFONYLUREA DERIVATIVE;

ACUTE HEART INFARCTION; AGED; ARTICLE; ATHEROTHROMBOSIS; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; DIABETES MELLITUS; FEMALE; HEALTH CARE PERSONNEL; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEXICO; MORTALITY; PREVALENCE; STROKE; THROMBOSIS; VASCULAR DISEASE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME;

AGED; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MEXICO; MIDDLE AGED; PREVALENCE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77954915094     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20800     Document Type: Article

References (18)

1. Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747-1757.
2. Rosamond W, Flegal K, Furie K, et al; for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117: e25-e146.
3. Meaney E, Lara-Esqueda A, Ceballos-Reyes GM, et al. Cardiovascular risk factors in the urban Mexican population: the FRIMEX study. Public Health. 2007;121:378-384.
4. Mitchell BD, González Villalpando C, Arredondo Pérez B, et al. Myocardial infarction and cardiovascular risk factors in Mexico City and San Antonio, Texas. Arterioscler Thromb Vasc Biol. 1995; 15:721-725.
5. Droste DW, Ringelstein EB. Evaluation of progression and spread of atherothrombosis. Cerebrovasc Dis. 2002;13(suppl 1):7-11.
6. Coccheri S; for CAPRIE Investigators. Distribution of symptomatic atherothrombosis and influence of the atherosclerotic disease burden on risk of secondary ischemic events: results from CAPRIE. Eur Heart J. 1998;19:1268.
7. Bhatt DL, Topol EJ. Antiplatelet and anticoagulant therapy in the secondary prevention of ischemic heart disease. Med Clin North Am. 2000;84:163-179. (Pubitemid 30068897)
8. Bhatt DL, Steg PG, Ohman EM, et al; for the REACH Registry Investigators. International prevalence, recognition, and treatment of cardiovascularrisk factors in outpatients with atherothrombosis. JAMA. 2006;295:180-189.
9. Steg G, Bhatt DL, Wilson PWF, et al; for the REACH Registry Investigators. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007;297:1197-1206.
10. Ohman EM, Bhatt DL, Steg G, et al; for the REACH Registry Investigators. The Reduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events - study design. Am Heart J. 2006;151: 786e1-786e10.
11. Chang IM, Gelman R, Pagano M. Corrected group prognostic curves and summary statistics. J Chron Dis. 1982;35:669-674. (Pubitemid 12099867)
12. Instituto Nacional de Estadística y Geografia (INEGI), México. Statistics on general mortality [in Spanish]. http://www.inegi.org.mx. Accessed February 15, 2010.
13. Fowkes FG, Low LP, Tuta S, et al; for AGATHA Investigators. Ankle-brachial index and extent of atherothrombosis in 8891 patients with or at risk of vascular disease: results of the international AGATHA study. Eur Heart J. 2006;27:1861-1867.
14. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317-1324.
15. Schargrodsky H, Hernández-Hernández R, Champagne BM, et al; for CARMELA Study Investigators. CARMELA: assessment of cardiovascular risk in seven Latin American cities. Am J Med. 2008;121:58-65.
16. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice. Eur Heart J. 2003;24:1601-1610.
17. Smith SC Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol. 2006;47:2130-2139.
18. Sanz J, Moreno PR, Fuster V. The year in atherothrombosis. J Am Coll Cardiol. 2008;51:944-955.